Healthy Skepticism Library item: 3522
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
MaLAM letter follow up—Bayer
MaLAM Newsletter 1987 Oct;
Abstract:
Bayer has acknowledged that its claims about ampicillin were misleading but has not provided Indonesian doctors with corrective information. Bayer has set up an International Marketing Quality Control Unit. MaLAM will monitor the functioning of that unit.
Keywords:
*analysis/Indonesia/developing countries/ampicillin/Bayer/antibiotics/company responses/ monitoring of compliance/MaLAM/Medical Lobby for Appropriate Marketing/ATTITUDES REGARDING PROMOTION: INDUSTRY/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES